These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31313595)

  • 1. Thiazole in the targeted anticancer drug discovery.
    Ayati A; Emami S; Moghimi S; Foroumadi A
    Future Med Chem; 2019 Aug; 11(15):1929-1952. PubMed ID: 31313595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Potential of Thiazole Derivatives: A Retrospective Review.
    Jain S; Pattnaik S; Pathak K; Kumar S; Pathak D; Jain S; Vaidya A
    Mini Rev Med Chem; 2018; 18(8):640-655. PubMed ID: 29173166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues.
    de Siqueira LRP; de Moraes Gomes PAT; de Lima Ferreira LP; de Melo Rêgo MJB; Leite ACL
    Eur J Med Chem; 2019 May; 170():237-260. PubMed ID: 30904782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of imidazo[2,1-b]thiazole-based anticancer agents in one decade (2011-2020): Current status and future prospects.
    Sbenati RM; Semreen MH; Semreen AM; Shehata MK; Alsaghir FM; El-Gamal MI
    Bioorg Med Chem; 2021 Jan; 29():115897. PubMed ID: 33316752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Patents on Thiazole Derivatives Endowed with Antitumor Activity.
    Morigi R; Locatelli A; Leoni A; Rambaldi M
    Recent Pat Anticancer Drug Discov; 2015; 10(3):280-97. PubMed ID: 26152151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazole and Related Heterocyclic Systems as Anticancer Agents: A Review on Synthetic Strategies, Mechanisms of Action and SAR Studies.
    Sahil ; Kaur K; Jaitak V
    Curr Med Chem; 2022 Aug; 29(29):4958-5009. PubMed ID: 35306982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
    Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
    Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Applications of Benzimidazole as a Privileged Scaffold in Drug Discovery.
    Guo Y; Hou X; Fang H
    Mini Rev Med Chem; 2021; 21(11):1367-1379. PubMed ID: 32753010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-proliferative activity of some new quinoline based 4,5-dihydropyrazoles and their thiazole hybrids as EGFR inhibitors.
    George RF; Samir EM; Abdelhamed MN; Abdel-Aziz HA; Abbas SE
    Bioorg Chem; 2019 Mar; 83():186-197. PubMed ID: 30380447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as novel anticancer agents: synthesis, biological evaluation, and structure-activity relationships.
    Lu Y; Li CM; Wang Z; Ross CR; Chen J; Dalton JT; Li W; Miller DD
    J Med Chem; 2009 Mar; 52(6):1701-11. PubMed ID: 19243174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic and Medicinal Perspective of Fused-Thiazoles as Anticancer Agents.
    Pawar S; Kumar K; Gupta MK; Rawal RK
    Anticancer Agents Med Chem; 2021; 21(11):1379-1402. PubMed ID: 32723259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents.
    Wan Y; Long J; Gao H; Tang Z
    Eur J Med Chem; 2021 Jan; 210():112953. PubMed ID: 33148490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highlights on Specific Biological Targets; Cyclin-Dependent Kinases, Epidermal Growth Factor Receptors, Ras Protein, and Cancer Stem Cells in Anticancer Drug Development.
    Hawash M
    Drug Res (Stuttg); 2019 Sep; 69(9):471-478. PubMed ID: 31083741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery.
    Ayati A; Emami S; Asadipour A; Shafiee A; Foroumadi A
    Eur J Med Chem; 2015 Jun; 97():699-718. PubMed ID: 25934508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel Thieno[2,3-d]pyrimidin-4-yl hydrazone-based cyclin-dependent kinase 4 inhibitors: synthesis, biological evaluation and structure-activity relationships.
    Horiuchi T; Takeda Y; Haginoya N; Miyazaki M; Nagata M; Kitagawa M; Akahane K; Uoto K
    Chem Pharm Bull (Tokyo); 2011; 59(8):991-1002. PubMed ID: 21804244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in vitro anticancer evaluation and in silico studies of novel imidazo[2,1-b]thiazole derivatives bearing pyrazole moieties.
    Ali AR; El-Bendary ER; Ghaly MA; Shehata IA
    Eur J Med Chem; 2014 Mar; 75():492-500. PubMed ID: 24576591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, computational studies, synthesis and biological evaluation of thiazole-based molecules as anticancer agents.
    Anuradha ; Patel S; Patle R; Parameswaran P; Jain A; Shard A
    Eur J Pharm Sci; 2019 Jun; 134():20-30. PubMed ID: 30965082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives.
    Al-Said MS; Bashandy MS; Al-Qasoumi SI; Ghorab MM
    Eur J Med Chem; 2011 Jan; 46(1):137-41. PubMed ID: 21093116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituted thiazoles VII. Synthesis and antitumor activity of certain 2-(substituted amino)-4-phenyl-1,3-thiazole analogs.
    Hassan GS; El-Messery SM; Al-Omary FA; El-Subbagh HI
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6318-23. PubMed ID: 22995621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
    Park JH; El-Gamal MI; Lee YS; Oh CH
    Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.